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The author stresses that the results have
been largely disappointing and are awaiting
new active agents and models with which the
most effective use of the agents available
could be established.
This is a book concentrating on human
malignancy written for clinicians, and pro-
vides a readable account of a complicated
field which continues to develop rapidly. It
rightly stresses that our knowledge is in-
complete, and provides a useful introduction
to tumour immunology. A number of texts
on this subject have recently appeared, and
the lack of a thorough consideration of the
animal model and effector mechanisms makes
this one less attractive as a book for general
recommendation.
B. M. VOSE
Controlled Therapeutic Trials in Cancer.
UICC Technical Report Series-Vol 32.
Eds. R. FLAMANT and C. FOHANNO (1978)
Geneva: International Union Against Can-
cer. 684 pp. 28.00 Sw. fr.
This volume is a comprehensive collection,
compiled by the UICC, of all clinical trials
registered with the UICC information office
by June 1977. The plan of data collection is
outlined in the introduction to the book, and
thereafter a series of tables defines the trial
according to the disease site, with further
details on the protocol and of the relevant
investigating unit. One of the major short-
comings in this volume is the lack of cross-
reference by means of an author index but,
none the less, for any group of practising
clinical research oncologists this is an impor-
tant summary of currently registered ongoing
trials in malignant disease. Although it is
unlikely that any individual would want to
possess such a volume, it will be an invaluable
reference for an oncological library.
H. BusH
Comprehensive Immunology. No. 4 Im-
munopathology of Lymphoreticular
Neoplasias. Eds. R. A. GOOD and 8. B.
DAY (1979) New York: Plenum Press.
763 pp. £28.35.
So rapid has been the expansion of our
knowledge of the immunopathology of lym-
phoreticular neoplasia that it seems scarcely
10 years since the discussion of these malig-
nancies was dominated exclusively by mor-
phological considerations and clinical mat-
ters. The combined fields of immunology,
cytochemistry and immunochemistry have
opened new approaches wNhich have quickly
proved applicable to the study oflymphomas.
The cytoidentity of primary neoplastic cells
is nowr more clearly recognized and their
clonal nature has been established. More
subtle immunological perturbations have
also become apparent.
This voluine lives up to the title ofthe series
of which it is the 4th of 5 parts (to date), in
that the degree of coverage approaches
monumental proportions. An initial series of
chapters provides the normal structural and
functional framewNork for the aberrations of
the lymphoid system wrhich follow%. These
include contributions on lymphoid-tissue
development, immunoregulation and ageing
and involution of the immune apparatus.
The high frequency of cancers in patients
with either primary genetically determined or
iatrogenic immunodeficiency is discussed in
excellent chapters by B. Spector and col-
leagues, and I. Penn respectively. In the
former, the results of an international effort
to collect data on cancers in patients with
primary immunodeficiences are presented,
and in the latter there is the encouraging fact
that disseminated cancers arising from malig-
nant cells inadvertently present in trans-
planted organs, can be eradicated on restora-
tion of immune function.
The application of the marker techniques
wNrhich have provided new criteria ofclassifica-
tion and analysis is discussed in 2 lucid
chapters by F. P. Seigal (Cytoidentity of
lymphoreticular neoplasias) and E. C. Frank-
lin and J. Buxbaum (Immunoglobulins in
the normal state and in neoplasias of B cells).
These contributions provide the rationale
for eventual prevention and improved treat-
ment, particularly since the technical ad-
vances therein described now make it possible
in some instances to identify the cell of origin
of the lymphomas.
This volume also contains a number of
presentations which should be useful to the
clinician. S. A. Rosenberg contributes a
chapter on the Treatment of Primary Lym-
phoid Neoplasias, and elsewhere in the book
Hodgkin's Disease receives much attention.
Perhaps of greatest clinical interest, however,
is a chapter (by R. H. Marshak ande.colleagues)